Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update in aortic valve diseases].

Alik Sagie1, Mordehay Vaturi, Yaron Shapira

  • 1Echocardiography Unit and Valvular Clinic, Cardiology Department, Rabin Medical Center. asagie@post.tau.ac.il

Harefuah
|December 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Low Alanine Aminotransferase in Patients Undergoing Transcatheter Aortic Valve Replacement.

JACC. Cardiovascular interventions·2026
Same author

Evaluating the effect of renin-angiotension-aldosterone system inhibitors and beta blockers on the progression of bicuspid aortic valve aortopathy in adulthood: A retrospective cohort study.

International journal of cardiology. Congenital heart disease·2026
Same author

Transcatheter aortic valve replacement infective endocarditis presenting as ascending aorta false aneurysm-a new clinical entity?

JTCVS techniques·2026
Same author

Prognostic Implications of Chronic Kidney Disease Stage on Outcomes After Percutaneous Coronary Intervention.

Journal of cardiovascular development and disease·2026
Same author

Percutaneous Edge-to-Edge Repair of Atrioventricular Valves in Congenital Heart Disease: A Multicenter Clinical Experience.

JACC. Advances·2025
Same author

Outcomes of Acurate Neo 2 Sapien 3 and Evolut Pro/Pro+ in Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2025
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Aortic valve disease, including stenosis and regurgitation, is the most common heart valve condition. Current treatments focus on surgical valve replacement, with new guidelines offering updated management strategies.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Medical Guidelines

Context:

  • Aortic valve disease is the most prevalent valve pathology, affecting up to 5% of the elderly population.
  • It represents a leading indication for cardiac and valve surgery, accounting for 60% of valve diseases in Europe.
  • Key drivers include congenital bicuspid aortic valves and degenerative changes in an aging demographic.

Purpose:

  • To review recent advancements in understanding aortic valve disease pathophysiology.
  • To highlight innovations in diagnostic techniques for aortic valve stenosis and regurgitation.
  • To analyze the latest ACC/AHA 2006 guidelines for valvular heart disease management, comparing them with prior guidelines and European recommendations.

Summary:

  • This review details the pathophysiology, diagnosis, and treatment of aortic valve diseases, emphasizing the 2006 ACC/AHA guidelines.

Related Experiment Videos

  • It discusses the significant clinical impact of aortic valve disease, for which surgical aortic valve replacement remains the primary therapy.
  • Comparative analysis includes older ACC/AHA guidelines and current European guidelines for valvular heart disease.

    • Impact:

    • Provides an updated perspective on aortic valve disease management based on new clinical guidelines.
    • Facilitates informed clinical decision-making by comparing different guideline recommendations.
    • Contributes to the understanding of evolving strategies for a common and serious cardiac condition.